from Pinnacle BioLabs
Their test has been the bestselling colon cancer screening test in the United States for 6 consecutive years. Pro's of the Second Generation FIT® test include it's OTC designation with the US Food and Drug Administration, it's affordability compared with similar products, ease of use, easy to find, and the fastest results.
The company was founded in 2011 and started producing consumer tests in 2016. The FIT test can be ordered over-the-counter for use in testing for blood in the stool. Pinnacle BioLabs indicates that its test detects globlin (proteins found in blood) levels at 50 ng/mL (50 billionths of a gram) with 98% sensitivity and 96% specificity.